Lung cancer mortality attributable to residential radon: a systematic scoping review.
Indoor air
Mortality burden
Naturally occurring radiation
Residential exposure
Journal
Journal of exposure science & environmental epidemiology
ISSN: 1559-064X
Titre abrégé: J Expo Sci Environ Epidemiol
Pays: United States
ID NLM: 101262796
Informations de publication
Date de publication:
05 2023
05 2023
Historique:
received:
02
03
2022
accepted:
24
11
2022
revised:
24
11
2022
medline:
5
6
2023
pubmed:
29
12
2022
entrez:
28
12
2022
Statut:
ppublish
Résumé
After smoking, residential radon is the second risk factor of lung cancer in general population and the first in never-smokers. Previous studies have analyzed radon attributable lung cancer mortality for some countries. We aim to identify, summarize, and critically analyze the available data regarding the mortality burden of lung cancer due to radon, performing a quality assessment of the papers included, and comparing the results from different countries. We performed a systematic scoping review using the main biomedical databases. We included original studies with attributable mortality data related to radon exposure. We selected studies according to specific inclusion and exclusion criteria. PRISMA 2020 methodology and PRISMA Extension for Scoping Reviews requirements were followed. Data were abstracted using a standardized data sheet and a tailored scale was used to assess quality. We selected 24 studies describing radon attributable mortality derived from 14 different countries. Overall, 13 studies used risk models based on cohorts of miners, 8 used risks from residential radon case-control studies and 3 used both risk model options. Radon geometric mean concentration ranged from 11 to 83 Becquerels per cubic meter (Bq/m
Identifiants
pubmed: 36577801
doi: 10.1038/s41370-022-00506-w
pii: 10.1038/s41370-022-00506-w
doi:
Substances chimiques
Radon
Q74S4N8N1G
Air Pollutants, Radioactive
0
Types de publication
Systematic Review
Journal Article
Review
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
368-376Informations de copyright
© 2022. The Author(s), under exclusive licence to Springer Nature America, Inc.
Références
World Health Organization. Global Health Estimates 2019: Deaths by Cause, Age, Sex, by Country and by Region, 2000-2019. 2020. https://www.who.int/data/gho/data/themes/mortality-and-global-health-estimates/ghe-leading-causes-of-death
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209–49. https://doi.org/10.3322/caac.21660 .
doi: 10.3322/caac.21660
pubmed: 33538338
Stewart BW, Wild CP. World cancer report 2014. Lyon, France: International Agency for Research on Cancer; 2014:16–53.
World Health Organization. WHO handbook on indoor radon: a public health perspective. Geneva, Switzerland: World Health Organization; 2009.
IARC (International Agency for Research on Cancer). IARC monographs on the evaluation of the carcinogenic risks to humans.volume 43: man-made mineral fibres and radon. Lyon: World Health Organization, International Agency for Research on Cancer; 1988.
Darby S, Hill D, Doll R. Radon: A likely carcinogen at all exposures. Ann Oncol. 2001;12:1341–51.
pubmed: 11762803
NRC (National Research Council). Health effects of exposure to radon: BEIR VI. Washington (DC): National Academies Press; 1999. https://pubmed.ncbi.nlm.nih.gov/25121310/ .
Lubin J, Wang Z, Boice J, Xu Z, Blot W, De Wang L, et al. Risk of lung cancer and residential radon in China: pooled results of two studies. Int J Cancer. 2004;109:132–7. https://pubmed.ncbi.nlm.nih.gov/14735479/ .
pubmed: 14735479
Krewski D, Lubin JH, Zielinski JM, Alavanja M, Catalan VS, Field RW, et al. Residential radon and risk of lung cancer: a combined analysis of 7 North American case-control studies. Epidemiology. 2005;16:137–45.
pubmed: 15703527
Darby S, Hill D, Auvinen A, Barros-Dios JM, Baysson H, Bochicchio F, et al. Radon in homes and risk of lung cancer: collaborative analysis of individual data from 13 European case-control studies. Br Med J. 2005;330:223–6.
Darby S, Hill D, Deo H, Auvinen A, Barros-Dios J, Baysson H, et al. Residential radon and lung cancer–detailed results of a collaborative analysis of individual data on 7148 persons with lung cancer and 14,208 persons without lung cancer from 13 epidemiologic studies in Europe. Scand J Work Environ Health. 2006;32:1–84. https://pubmed.ncbi.nlm.nih.gov/16538937/ .
pubmed: 16538937
Rockhill B, Newman B, Weinberg C. Use and misuse of population attributable fractions. Am J Public Health. 1998;88:15–9.
pubmed: 9584027
pmcid: 1508384
Kim S-H, Hwang WJ, Cho J-S, Kang DR. Attributable risk of lung cancer deaths due to indoor radon exposure. Ann Occup Environ Med. 2016;28. https://doi.org/10.1186/s40557-016-0093-4
Ajrouche R, Ielsch G, Cléro E, Roudier C, Gay D, Guillevic J, et al. Quantitative health risk assessment of indoor radon: a systematic review. radiat prot dosimetry. 2017;177:69–77. https://academic.oup.com/rpd/article/177/1-2/69/4161654
Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD. et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n21 https://www.bmj.com/content/372/bmj.n71 .
Tricco AC, Lillie E, Zarin W, O’Brien KK, Colquhoun H, Levac D, et al. PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med. 2018;169:467–73.
pubmed: 30178033
Wells GA, Shea B, O’Connel D, Peterson J, Welch V, Losos M, et al. The Newcastle-Ottawa scale (NOS) for assessing the quailty of nonrandomised studies in meta-analyses. 2009. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp
Pérez-Ríos M, Rey-Brandariz J, Galán I, Fernández E, Montes A, Santiago-Pérez MI, et al. Methodological guidelines for the estimation of attributable mortality using a prevalence-based method: the STREAMS-P tool. J Clin Epidemiol. 2022;147:101–10. https://pubmed.ncbi.nlm.nih.gov/35341948/ .
pubmed: 35341948
Ayotte P, Lévesque B, Gauvin D, McGregor RG, Martel R, Gingras S, et al. Indoor exposure to 222Rn: a public health perspective. Health Phys. 1998;75:297–302.
pubmed: 9721839
Leenhouts H, Brugmans M. Calculation of the 1995 lung cancer incidence in The Netherlands and Sweden caused by smoking and radon: risk implications for radon. Radiat Environ Biophys. 2001;40:11–21. https://pubmed.ncbi.nlm.nih.gov/11357706/ .
pubmed: 11357706
Gaskin J, Coyle D, Whyte J, Krewksi D. Global estimate of lung cancer mortality attributable to residential radon. Environ Health Perspect. 2018;126:057009.
Axelsson G, Andersson EM, Barregard L. Lung cancer risk from radon exposure in dwellings in Sweden: how many cases can be prevented if radon levels are lowered? Cancer Causes Control. 2015;26:541–7.
pubmed: 25677843
pmcid: 4365178
Gredner T, Behrens G, Stock C, Brenner H, Mons U. Cancers due to infection and selected environmental factors. Dtsch Arztebl Int. 2018;115:586–93.
pubmed: 30236218
pmcid: 6206252
Grundy A, Brand K, Khandwala F, Poirier A, Tamminen S, Friedenreich CM, et al. Lung cancer incidence attributable to residential radon exposure in Alberta in 2012. CMAJ Open. 2017;5:E529–34.
pubmed: 28663187
pmcid: 5498175
Gaskin J, Coyle D, Whyte J, Krewski D. Utility gains from reductions in the modifiable burden of lung cancer attributable to residential radon in Canada. Can J Public Health. 2018;109:598–609. https://pubmed.ncbi.nlm.nih.gov/30264193/ .
pubmed: 30264193
pmcid: 6964607
Al-arydah M. Estimating the burden of lung cancer and the efficiency of home radon mitigation systems in some Canadian provinces. Sci Total Environ. 2018;626:287–306.
pubmed: 29353778
Al-Arydah M. Comparing health effects of radon in manitoba and prince edward island. Radiat Prot Dosim. 2020;191:197–201.
Li P, Deng S, Wang J, Iwata A, Qiao Y, Dai X, et al. Occupational and environmental cancer incidence and mortality in China. Occup Med. 2012;62:281–7. https://pubmed.ncbi.nlm.nih.gov/22411970/ .
Rushton L, Bagga S, Bevan R, Brown T, Cherrie J, Holmes P, et al. Occupation and cancer in Britain. Br J Cancer. 2010;102:1428–37. https://pubmed.ncbi.nlm.nih.gov/20424618/ .
pubmed: 20424618
pmcid: 2865752
Veloso B, Nogueira JR, Cardoso MF. Lung cancer and indoor radon exposure in the north of Portugal - an ecological study. Cancer Epidemiol. 2012;36:e26–e32.
pubmed: 22075535
Pérez-Ríos M, Barros-Dios JM, Montes-Martínez A, Ruano-Ravina A. Attributable mortality to radon exposure in Galicia, Spain. Is it necessary to act in the face of this health problem? BMC Public Health. 2010;10:256.
pubmed: 20482770
pmcid: 2885334
Peterson E, Aker A, Kim J, Li Y, Brand K, Copes R. Lung cancer risk from radon in Ontario, Canada: how many lung cancers can we prevent? Cancer Causes Control. 2013;24:2013–20.
pubmed: 23982909
pmcid: 3824583
Truta-Popa LA, Dinu A, Dicu T, Szacsvai K, Cosma C, Hofmann W. Preliminary lung cancer risk assessment of exposure to radon progeny for transylvania, Romania. Health Phys. 2010;99:301–7.
pubmed: 20699690
Steindorf K, Lubin J, Wichmann H, Becher H. Lung cancer deaths attributable to indoor radon exposure in West Germany. Int J Epidemiol. 1995;24:485–92. https://pubmed.ncbi.nlm.nih.gov/7672886/ .
pubmed: 7672886
Menzler S, Piller G, Gruson M, Rosario A, Wichmann H, Kreienbrock L. Population attributable fraction for lung cancer due to residential radon in Switzerland and Germany. Health Phys. 2008;95:179–89.
pubmed: 18617799
Al-arydah M. Population attributable risk associated with lung cancer induced by residential radon in Canada: Sensitivity to relative risk model and radon probability density function choices: In memory of Professor Jan M. Zielinski. Sci Total Environ. 2017;596–597:331–41. https://pubmed.ncbi.nlm.nih.gov/28437651/ .
pubmed: 28437651
Lorenzo-Gonzalez M, Ruano-Ravina A, Torres-Duran M, Kelsey KT, Provencio M, Parente-Lamelas I, et al. Lung cancer risk and residential radon exposure: a pooling of case-control studies in northwestern Spain. Environ Res. 2020;189:109968.
pubmed: 32736146
Barros-Dios J, Barreiro M, Ruano-Ravina A, Figueiras A. Exposure to residential radon and lung cancer in Spain: a population-based case-control study. Am J Epidemiol. 2002;156:548–55. https://pubmed.ncbi.nlm.nih.gov/12226002/ .
pubmed: 12226002
Schram-Bijkerk D, van Kempen E, Knol A. The burden of disease related to indoor air in the Netherlands: do different methods lead to different results? Occup Environ Med. 2013;70:126–32. https://pubmed.ncbi.nlm.nih.gov/23204013/
Wang J, Fan Y, Jiang Y, Li P, Xiao H, Chen W, et al. Attributable causes of lung cancer incidence and mortality in China. Thorac Cancer. 2011;2:156–63. https://pubmed.ncbi.nlm.nih.gov/27755858/ .
pubmed: 27755858
Kim S, Koh S, Lee C, Kim C, Kang D. Indoor radon and lung cancer: estimation of attributable risk, disease burden, and effects of mitigation. Yonsei Med J. 2018;59:1123–30. https://pubmed.ncbi.nlm.nih.gov/30328328/ .
pubmed: 30328328
pmcid: 6192894
Gray A, Read S, McGale P, Darby S. Lung cancer deaths from indoor radon and the cost effectiveness and potential of policies to reduce them. BMJ. 2009;338:215–8.
Catelinois O, Rogel A, Laurier D, Billon S, Hemon D, Verger P, et al. Lung cancer attributable to indoor radon exposure in France: impact of the risk models and uncertainty analysis. Environ Health Perspect. 2006;114:1361–6. https://doi.org/10.1289/ehp.9070 .
doi: 10.1289/ehp.9070
pubmed: 16966089
pmcid: 1570096
Ajrouche R, Roudier C, Cléro E, Ielsch G, Gay D, Guillevic J, et al. Quantitative health impact of indoor radon in france. Radiat Environ Biophys. 2018;57:205–14.
pubmed: 29737422
Ruano-Ravina A, Varela-Lema L, García Talavera M, García Gómez M, González Muñoz S, Santiago-Pérez M, et al. Lung cancer mortality attributable to residential radon exposure in Spain and its regions. Environ Res. 2021;199. https://pubmed.ncbi.nlm.nih.gov/34051201/
Lee HA, Lee WK, Lim D, Park SH, Baik SJ, Kong KA, et al. Risks of lung cancer due to radon exposure among the regions of Korea. J Korean Med Sci. 2015;30:542–8.
pubmed: 25931783
pmcid: 4414636
Hunter N, Muirhead C, Bochicchio F, Haylock R. Calculation of lifetime lung cancer risks associated with radon exposure, based on various models and exposure scenarios. J Radio Prot. 2015;35:539–55. https://pubmed.ncbi.nlm.nih.gov/26083042/ .
Brand K, Zielinski J, Krewski D. Residential radon in Canada: an uncertainty analysis of population and individual lung cancer risk. Risk Anal. 2005;25:253–69. https://pubmed.ncbi.nlm.nih.gov/15876202/ .
pubmed: 15876202
Chen J, Moir D, Whyte J. Canadian population risk of radon induced lung cancer: a re-assessment based on the recent cross-Canada radon survey. Radiat Prot Dosim. 2012;152:9–13.
Bochicchio F, Antignani S, Venoso G, Forastiere F. Quantitative evaluation of the lung cancer deaths attributable to residential radon: a simple method and results for all the 21 Italian Regions. Radiat Meas. 2013;50:121–6.
Lubin J, Boice J. Estimating Rn-induced lung cancer in the United States. Health Phys. 1989;57:417–27. https://pubmed.ncbi.nlm.nih.gov/2777548/ .
pubmed: 2777548
Ángeles A, Espinosa G. Lung cancer mortality from exposure to indoor radon (222Rn) in Mexico. Adv Res. 2015;5:1–9. https://www.journalair.com/index.php/AIR/article/view/18138 .
Puskin J, Yang Y. A retrospective look at Rn-induced lung cancer mortality from the viewpoint of a relative risk model. Health Phys. 1988;54:635–43. https://pubmed.ncbi.nlm.nih.gov/3378895/ .
pubmed: 3378895
Pawel D, Puskin J. The U.S. Environmental Protection Agency’s assessment of risks from indoor radon. Health Phys. 2004;87:68–74. https://pubmed.ncbi.nlm.nih.gov/15194924/ .
pubmed: 15194924
Cao X, MacNaughton P, Laurent J, Allen J. Radon-induced lung cancer deaths may be overestimated due to failure to account for confounding by exposure to diesel engine exhaust in BEIR VI miner studies. PLoS ONE. 2017;12:e0184298. https://pubmed.ncbi.nlm.nih.gov/28886109/ .
pubmed: 28886109
pmcid: 5590909